Frontlight ResearchEarly access
Taking peopleNo phase
STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision
Key facts
- Who runs it
- Canadian Cancer Trials Group
- Where
- Canada and New Zealand12 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 249 people, planned
- Started
- 10 Dec 2024
- Expected to end
- 30 Nov 2031
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Surgery
- Active Surveillance
- Record updated
- 11 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Histologically confirmed diagnosis of vulvar squamous cell carcinoma (VSCC)
- Surgically staged FIGO I-II VSCC as per FIGO 2021 guidelines
- Vulvar resection according to standard of care guidelines
- Post-operative margin assessment of tumour clearance, dVIN and p53 status
- Participants' age must be ≥ 18 years old
- Participant is able (i.e. sufficiently fluent) and willing to complete the quality of life and/or health utility questionnaires in either English or French
- Participant's consent must be appropriately obtained in accordance with applicable local and regulatory requirements
Who cannot take part
- Participants referred for/receiving/or previously received adjuvant vulvar radiation or chemotherapy
- Surgical margins positive for invasive cancer
- Participants with a history of other malignancies, except: adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumours curatively treated with no evidence of disease for ≥ 5 years
- Recurrent vulvar squamous cell carcinoma
- Non-squamous cell carcinoma histotypes
- Primary tumour HPV-I p53 wild-type VSCC
- Lymph node positive VSCC or lymph nodes with isolated tumour cells
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is being done to answer the following question: Are there types of early-stage vulvar cancer that require either less or more treatment than the usual approach?
The 3 groups in the trial
- Sub-Study A: Active SurveillanceExisting treatment, for comparison
If the laboratory test results show vulvar cancer is caused by HPV
Treatment: Active Surveillance
- Sub-Study B: Re-excisionExisting treatment, for comparison
If the laboratory test results show vulvar cancer is not caused by HPV
Treatment: Surgery
- Sub-Study B: Active SurveillanceExisting treatment, for comparison
If the laboratory test results show vulvar cancer is not caused by HPV
Treatment: Active Surveillance
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
- Record updated
- 11 August 2026